Search Results - "Huper, G"

Refine Results
  1. 1
  2. 2

    DHH1 regulates the G1/S-checkpoint following DNA damage or BRCA1 expression in yeast by WESTMORELAND, T. J, OLSON, J. A, SAITO, W. Y, HUPER, G, MARKS, J. R, BENNETT, C. B

    Published in The Journal of surgical research (01-07-2003)
    “…Heterologous expression of the tumor suppressor BRCA1 in the yeast Saccharomyces cerevisiae is lethal. To identify potential new BRCA1-interacting gene…”
    Get full text
    Conference Proceeding Journal Article
  3. 3

    Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer by Kerns, B J, Jordan, P A, Huper, G, Marks, J R, Iglehart, J D, Layfied, L J

    Published in Modern pathology (01-11-1993)
    “…The c-erbB-2 (HER-2/neu) proto-oncogenes is important in oncogenesis and for determination of prognosis in a number of human malignancies. DNA (Southern)…”
    Get more information
    Journal Article
  4. 4

    c-erbB-2 expression in breast cancer detected by immunoblotting and immunohistochemistry by Kerns, BJ, Pence, JC, Huper, G, Kinney, RB, Iglehart, JD

    “…Evidence that the c-erbB-2 proto-oncogene is important in prognosis and oncogenesis in a number of human malignancies is increasing. DNA (Southern)…”
    Get full text
    Journal Article
  5. 5

    Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer by Wang, Wei, Huper, Gudrun, Guo, Yueqi, Murphy, Susan K, Olson, Jr, John A, Marks, Jeffrey R

    Published in Oncogene (14-04-2005)
    “…Treatment of the breast cancer cell line, MDAMB468 with the DNA methylation inhibitor, 5-azacytidine (5-AzaC) results in growth arrest, whereas the growth of…”
    Get full text
    Journal Article
  6. 6

    Evaluation of expression based markers for the detection of breast cancer cells by BROWN, Nicholas M, STENZEL, Timothy T, FRIEDMAN, Paula N, HENSLEE, Jerry, HUPER, Gudrun, MARKS, Jeffrey R

    Published in Breast cancer research and treatment (01-05-2006)
    “…Genes that are expressed in a highly tissue- or disease-specific manner provide possible targets for therapeutics, early detection of cancer, and monitoring of…”
    Get full text
    Journal Article
  7. 7

    Cell cycle control of BRCA2 by VAUGHN, J. P, CIRISANO, F. D, HUPER, G, BERCHUCK, A, FUTREAL, P. A, MARKS, J. R, IGLEHART, J. D

    Published in Cancer research (Chicago, Ill.) (15-10-1996)
    “…Identifying the conditions and kinetics of the induction of BRCA2 gene expression may implicate roles for the function of the tumor suppressor gene. In this…”
    Get full text
    Journal Article
  8. 8

    BRCA1 expression is not directly responsive to estrogen by MARKS, J. R, HUPER, G, VAUGHN, J. P, DAVIS, P. L, NORRIS, J, MCDONNELL, D. P, WISEMAN, R. W, FUTREAL, P. A, IGLEHART, J. D

    Published in Oncogene (09-01-1997)
    “…Expression of the breast cancer susceptibility gene, BRCA1, is induced by 17-beta estradiol (E2) in estrogen receptor containing breast cancer cell lines. Our…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Dhh1 regulates the G1/S-checkpoint following DNA damage or BRCA1 expression in yeast 1 by Westmoreland, T.J, Olson, J.A, Saito, W.Y, Huper, G, Marks, J.R, Bennett, C.B

    Published in The Journal of surgical research (2003)
    “…Heterologous expression of the tumor suppressor BRCA1 in the yeast Saccharomyces cerevisiae is lethal. To identify potential new BRCA1-interacting gene…”
    Get full text
    Journal Article
  11. 11

    Increased erbB-2 gene copies and expression in multiple stages of breast cancer by DIRK IGLEHART, J, KRAUS, M. H, LANGTON, B. C, HUPER, G, KERNS, B. J, MARKS, J. R

    Published in Cancer research (Chicago, Ill.) (15-10-1990)
    “…In order to examine the role of the erbB-2 oncogene in human breast cancer, gene amplification and expression were examined in multiple stages of tumor…”
    Get full text
    Journal Article
  12. 12

    Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer by IGLEHART, J. D, KERNS, B.-J, HUPER, G, MARKS, J. R

    Published in Breast cancer research and treatment (01-06-1995)
    “…Ductal carcinoma in situ (intraductal carcinoma) of the breast is a commonly recognized and curable clinical entity. Patients with intraductal carcinoma are at…”
    Get full text
    Journal Article
  13. 13

    Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells by Davis, P, Bazar, K, Huper, G, Lozano, G, Marks, J, Iglehart, J D

    Published in Oncogene (19-09-1996)
    “…The p53 gene is a recessive oncogene whose loss of function can result in cell transformation. Approximately 25% of human breast cancers contain missense…”
    Get more information
    Journal Article
  14. 14

    Loss of heterozygosity for genes on 11p and the clinical course of patients with lung carcinoma by Skinner, M A, Vollmer, R, Huper, G, Abbott, P, Iglehart, J D

    Published in Cancer research (Chicago, Ill.) (15-04-1990)
    “…Forty-five primary human lung carcinomas were evaluated for the loss of heterozygosity for genes on the short end of chromosome 11. Of 40 evaluable…”
    Get full text
    Journal Article
  15. 15

    Mitosis is required for production of murine leukemia virus and structural proteins during de novo infection by P F Fischinger, N Tuttle-Fuller, G Hüper, D P Bolognesi

    Published in Journal of Virology (01-08-1975)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  16. 16

    Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis by LOBENHOFER, E. K, HUPER, G, IGLEHART, J. D, MARKS, J. R

    Published in Cell growth & differentiation (01-02-2000)
    “…Estrogen acts to promote DNA synthesis in the MCF-7 human breast cancer cell line via its interaction with high levels of estrogen receptor. The primary mode…”
    Get full text
    Journal Article
  17. 17

    Properties of mouse leukemia viruses. XIX. Effective antibody therapy of AKR leukemia occurs independently of virus neutralization and produces long-term changes in the virus status of the thymus by Weinhold, K J, Hüper, G, Matthews, T J, Fischinger, P J, Ihle, J N, Schwarz, H, Thiel, H J, Schäfer, W, Bolognesi, D P

    Published in Virology (New York, N.Y.) (01-05-1984)
    “…Administration of high-titered goat anti-FLV gp71 IgG to AKR mice during a narrow neonatal therapy "window" suppresses the early development of MuLV infectious…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Relative Promoter Activity in Human Mammary Epithelial Cells Assayed by Transient Expression by Gudrun Huper, Marks, Jeffrey R., Wiener, Jon R., Iglehart, J. Dirk

    “…Chimeric DNA expression vectors containing regulatory sequences proximal to the 5' end of coding sequences for mammalian genes provide valuable tools to study…”
    Get full text
    Journal Article